Zhejiang Jiuzhou Pharm Co Ltd (603456) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.032x

Based on the latest financial reports, Zhejiang Jiuzhou Pharm Co Ltd (603456) has a cash flow conversion efficiency ratio of 0.032x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥261.98 Million ≈ $38.34 Million USD) by net assets (CN¥8.11 Billion ≈ $1.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang Jiuzhou Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Zhejiang Jiuzhou Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zhejiang Jiuzhou Pharm Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Zhejiang Jiuzhou Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Jiuzhou Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Veris Residential Inc NYSE:VRE	0.011x
Guangdong Taienkang Pharmaceutical Co. Ltd SHE:301263	N/A
A10 Network NYSE:ATEN	0.107x
Sunwave Communications Co Ltd SHE:002115	-0.059x
Quick Intelligent Equipment Co Ltd SHG:603203	0.038x
Minmetals Development Co Ltd SHG:600058	0.187x
Aether Industries Limited NSE:AETHER	0.049x
Telling Telecommunication Holding Co Ltd SHE:000829	-0.234x

Annual Cash Flow Conversion Efficiency for Zhejiang Jiuzhou Pharm Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Jiuzhou Pharm Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Jiuzhou Pharm Co Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.61 Billion ≈ $1.26 Billion	CN¥991.66 Million ≈ $145.11 Million	0.115x	-27.75%
2023-12-31	CN¥8.53 Billion ≈ $1.25 Billion	CN¥1.36 Billion ≈ $199.06 Million	0.159x	-30.14%
2022-12-31	CN¥5.37 Billion ≈ $786.02 Million	CN¥1.23 Billion ≈ $179.37 Million	0.228x	+54.17%
2021-12-31	CN¥4.58 Billion ≈ $669.78 Million	CN¥677.52 Million ≈ $99.14 Million	0.148x	+14.09%
2020-12-31	CN¥3.09 Billion ≈ $451.60 Million	CN¥400.39 Million ≈ $58.59 Million	0.130x	-33.08%
2019-12-31	CN¥2.86 Billion ≈ $418.27 Million	CN¥554.16 Million ≈ $81.09 Million	0.194x	+103.41%
2018-12-31	CN¥2.78 Billion ≈ $406.52 Million	CN¥264.78 Million ≈ $38.75 Million	0.095x	-6.98%
2017-12-31	CN¥2.68 Billion ≈ $392.28 Million	CN¥274.68 Million ≈ $40.19 Million	0.102x	+92.47%
2016-12-31	CN¥2.57 Billion ≈ $375.60 Million	CN¥136.65 Million ≈ $20.00 Million	0.053x	-4.69%
2015-12-31	CN¥2.52 Billion ≈ $368.13 Million	CN¥140.53 Million ≈ $20.56 Million	0.056x	+769.76%
2014-12-31	CN¥1.58 Billion ≈ $231.68 Million	CN¥10.17 Million ≈ $1.49 Million	0.006x	-97.68%
2013-12-31	CN¥736.75 Million ≈ $107.81 Million	CN¥203.86 Million ≈ $29.83 Million	0.277x	+7.08%
2012-12-31	CN¥597.08 Million ≈ $87.37 Million	CN¥154.28 Million ≈ $22.58 Million	0.258x	+7.20%
2011-12-31	CN¥460.54 Million ≈ $67.39 Million	CN¥111.01 Million ≈ $16.24 Million	0.241x	--

About Zhejiang Jiuzhou Pharm Co Ltd

SHG:603456 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.77 Billion

CN¥12.10 Billion CNY

Market Cap Rank

#6756 Global

#1563 in China

Share Price

CN¥13.60

Change (1 day)

-1.38%

52-Week Range

CN¥13.60 - CN¥21.87

All Time High

CN¥60.21